Under the agreement, Exco InTouch will work with Almac for integrating its retention and compliance technology solutions with Almac’s IXRS technology.
The Almac-Exco InTouch offering serves a pressing need in the drug development process: Engaging, retaining, and enhancing compliance of patients from the earliest stages of recruitment and throughout the course of a trial.
The solution keeps patients on track during a trial and offers them an ‘electronic tap on the shoulder’ in their native languages to help drive compliance.
Exco InTouch president Jim Murphy said the alliance between Almac and Exco InTouch provides sponsors with a practical, cost-effective solution to managing patients during a clinical trial.
"Our joint solutions will help enhance patient recruitment, retention, and compliance, three highly critical areas of concern for our clients," Murphy said.